C15H21N3O2.C7H6O3
Neat
413.47
Physostigmine Salicylate
Physostigmine salicylate CRS
+5°C
Room Temperature
Physostigmine salicylate, (3aS, 8aR)-1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethylpyrrolo[2, 3-b]indol-5-yl methylcarbamate salicylate, Benzoic acid, 2-hydroxy-, compd. with (3aS, 8aR)-1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethylpyrrolo[2, 3-b]indol-5-yl methylcarbamate (1:1) (9CI), Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethylpyrrolo[2, 3-b]indol-5-yl methylcarbamate (1:1), Physostigmine salicylate (6CI), Physostigmine, monosalicylate (8CI), Pyrrolo[2, 3-b]indol-5-ol, 1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethyl-, methylcarbamate (ester), (3aS, 8aR)-, mono(2-hydroxybenzoate) (salt) (9CI), Pyrrolo[2, 3-b]indol-5-ol, 1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt), Salicylic acid, compd. with physostigmine (1:1) (8CI), (-)-Physostigmine salicylate, Eserine salicylate and Isopto Eserine
CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1.OC(=O)c4ccccc4O
[(3aR, 8bS)-3, 4, 8b-trimethyl-2, 3a-dihydro-1H-pyrrolo[2 and 3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid